These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22899340)

  • 1. Enhanced CD21 expression and shedding in chronic lymphatic leukemia: a possible pathomechanism in disease progression.
    Low HZ; Hilbrans D; Schmidt-Wolf IG; Illges H
    Int J Hematol; 2012 Sep; 96(3):350-6. PubMed ID: 22899340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
    Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
    Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
    Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E
    Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL.
    Nichols EM; Jones R; Watson R; Pepper CJ; Fegan C; Marchbank KJ
    Oncotarget; 2015 Oct; 6(32):32669-80. PubMed ID: 26452134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells.
    Frémeaux-Bacchi V; Fischer E; Lecoanet-Henchoz S; Mani JC; Bonnefoy JY; Kazatchkine MD
    Int Immunol; 1998 Oct; 10(10):1459-66. PubMed ID: 9796912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
    Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell activation leads to shedding of complement receptor type II (CR2/CD21).
    Masilamani M; Kassahn D; Mikkat S; Glocker MO; Illges H
    Eur J Immunol; 2003 Sep; 33(9):2391-7. PubMed ID: 12938215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectodomain shedding and generation of two carboxy-terminal fragments of human complement receptor 2/CD21.
    Hoefer MM; Illges H
    Mol Immunol; 2009 Aug; 46(13):2630-9. PubMed ID: 19524299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis.
    Masilamani M; von Kempis J; Illges H
    Rheumatology (Oxford); 2004 Feb; 43(2):186-90. PubMed ID: 12867574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathways controlling the expression of surface CD21 (CR2) and CD23 (Fc(epsilon)IIR) proteins in human malignant B cells.
    Shubinsky G; Schlesinger M; Polliack A; Rabinowitz R
    Leuk Lymphoma; 1997 May; 25(5-6):521-30. PubMed ID: 9250823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic reduction of soluble complement receptor II/CD21 during pregnancy to levels reminiscent of autoimmune disease.
    Masilamani M; Rajasekaran N; Singh A; Low HZ; Albus K; Anders S; Behne F; Eiermann P; König K; Mindnich C; Ribarska T; Illges H
    Rheumatol Int; 2008 Sep; 28(11):1137-41. PubMed ID: 18500464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of sCD21 in Human Blood Using ELISA is Influenced by Ethylenediaminetetraacetic Acid (EDTA) Containing Blood Collection Tubes.
    Linke K; Illges H
    Clin Lab; 2015; 61(11):1803-8. PubMed ID: 26732009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23.
    Frémeaux-Bacchi V; Bernard I; Maillet F; Mani JC; Fontaine M; Bonnefoy JY; Kazatchkine MD; Fischer E
    Eur J Immunol; 1996 Jul; 26(7):1497-503. PubMed ID: 8766552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD21 in sera and synovial fluid of arthritic patients.
    Grottenthaler T; von Kempis J; Goldacker S; Illges H
    Rheumatol Int; 2006 Jan; 26(3):240-3. PubMed ID: 15770483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The increased expression of CD21 on AchR specified B cells in patients with myasthenia gravis.
    Yin W; Allman W; Ouyang S; Li Y; Li J; Christadoss P; Yang H
    J Neuroimmunol; 2013 Mar; 256(1-2):49-54. PubMed ID: 23266128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of soluble CD21 from human plasma by affinity chromatography and density gradient centrifugation.
    Masilamani M; Apell HJ; Illges H
    J Immunol Methods; 2002 Dec; 270(1):11-8. PubMed ID: 12379334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lymphocytic leukemia/small lymphocytic lymphoma: another neoplasm related to the B-cell follicle?
    Tandon B; Swerdlow SH; Hasserjian RP; Surti U; Gibson SE
    Leuk Lymphoma; 2015; 56(12):3378-86. PubMed ID: 25860247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human B and T lymphocytes have similar amounts of CD21 mRNA, but differ in surface expression of the CD21 glycoprotein.
    Braun M; Melchers I; Peter HH; Illges H
    Int Immunol; 1998 Aug; 10(8):1197-202. PubMed ID: 9723706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The autocrine motility factor receptor is overexpressed on the surface of B cells in Binet C chronic lymphocytic leukemia.
    Grund S; Olsson B; Jernås M; Jacobsson S; Swolin B; Nabi IR; Carlsson L; Wadenvik H
    Med Oncol; 2011 Dec; 28(4):1542-8. PubMed ID: 20574759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates.
    Hartmann EM; Rudelius M; Burger JA; Rosenwald A
    Leuk Lymphoma; 2016; 57(3):563-71. PubMed ID: 26458057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.